
Encompass Health (EHC) Stock Forecast & Price Target
Encompass Health (EHC) Analyst Ratings
Bulls say
Encompass Health is well-positioned in the post-acute healthcare market with strong earnings and growth in SS volume. Despite potential risks, the company has a successful track record of expansion and a strong balance sheet. Their focus on EBITDA and margin growth, as well as their strategic prioritization of favorable markets and pilot programs, shows a commitment to continued success and potential for further growth. Additionally, the company has strong leadership and partnership with experienced executives and a history of success in the post-acute healthcare market.
Bears say
Encompass Health is facing potential risks from stricter reimbursement and regulatory measures, as well as slow recovery of demand and patient volume growth which is putting pressure on margins. Despite a strong balance sheet and management expertise, their prioritization of investing in existing facilities and partnerships for new facilities, and their position in the IRF market, they may face challenges with potential lower volume growth, slower ramp-up of new facilities, and pressure from Medicare Advantage payers in the future. Their successful growth strategy and plans to increase leverage for further growth opportunities may pose a potential risk if the economic climate changes or if they are unable to maintain their strong competitive position.
This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.
Encompass Health (EHC) Analyst Forecast & Price Prediction
Start investing in Encompass Health (EHC)
Order type
Buy in
Order amount
Est. shares
0 shares